# Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-2-trial-of-cemdisiran-in-adult-patients-with-iga-nephropathy-a-randomized/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jonathan Barratt,Adrian Liew,See Cheng Yeo,Anders Fernström,Sean J. Barbour,C. John Sperati,Russell Villanueva,Ming‐Ju Wu,Dazhe Wang,Anna Borodovsky,Prajakta Badri,Elena Yureneva,Ishir Bhan,Daniel Cattran,on behalf of the Cemdisiran Phase 2 Study Investigators and Collaborators |
| Citations | 69 |
| DOI | 10.2215/cjn.0000000000000384 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.2215/cjn.0000000000000384 |
| OpenAlex ID | https://openalex.org/W4390793335 |
| PMID | 38214599 |
| Type | article |
| Year | 2024 |

## Paper authors

- [See Cheng Yeo](https://scholariq.org/researchers/see-cheng-yeo/)

## Paper journal

- [Clinical Journal of the American Society of Nephrology](https://scholariq.org/journals/clinical-journal-of-the-american-society-of-nephrology/)

## Paper primary topic

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Paper topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.